LUMINOSITY trial

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

June, 2025

LUMINOSITY trial

May 16, 2025, 06:13 | Blog

IASLC - FDA Accelerated Approval of Emrelis for Advanced NSCLC

International Association for the Study of Lung Cancer (IASLC) posted on LinkedIn: "FDA Accelerated Approval…

May 14, 2025, 18:42 | Oncolibrary

FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS™) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer

On May 14, 2025, the U.S. Food and Drug Administration (FDA) granted accelerated approval for…

Oct 5, 2024, 08:24 | Insight

Tanja Obradovic: New Treatment for NSCLC Patients Targeting cMet Over-Expression

Tanja Obradovic shared a post on LinkedIn: "Novel antibody-drug conjugate (ADC) may be coming for…

Oct 3, 2024, 07:22 | Blog

Tanja Obradovic: AbbVie submitted telisotuzumab vedotin in adult NSCLC patients with tumors with EGFR non squamous histology

Tanja Obradovic shared a post on LinkedIn: "Completely new treatment option by novel antibody-drug conjugate (ADC)…

Aug 29, 2024, 17:01 | Insight

Elad Sharon: Quite promising for c-MET over-expressing NSCLC

Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, shared a post by Giuseppe Banna, Consultant…

Aug 27, 2024, 22:06 | Insight

Giuseppe Banna: Promising results for Telisotuzumab Vedotin in advanced NSCLC

Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared a post on…

All: 6 Posts: 1 - 100

'

15 Posts Not to Miss from the 1st Day of ASCO 2025

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023